Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)

Dariusz Dudek1*, MD, PhD; Roxana Mehran2,3, MD; Artur Dziewierz1, MD, PhD; Sorin J. Brener3,4, MD; Tomasz Rakowski1, MD, PhD; Michał Brzeziński1, MD; Bruce R. Brodie5, MD; Ke Xu3, PhD; Martin Fahy3, MSc; Alexandra J. Lansky6, MD; Krzysztof Żmudka1, MD, PhD; Gregg W. Stone3,7, MD

1. Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland; 2. Icahn School of Medicine at Mount Sinai, New York, NY, USA; 3. Cardiovascular Research Foundation, New York, NY, USA; 4. New York Me

Aims: Using the database from the large-scale, prospective, randomised HORIZONS-AMI trial, the authors sought to assess the impact of bifurcatio

Sign in to read and download the full article

Login Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bifurcation lesionpercutaneous coronary interventionst-segment elevation myocardial infarction

Share via Facebook Share via Twitter Share via LinkedIn Share by email

Read next article

Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approach